Supplementary Figure 2 from Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network
posted on 2023-03-31, 17:13authored byA. Ari Hakimi, Irina Ostrovnaya, Boris Reva, Nikolaus Schultz, Ying-Bei Chen, Mithat Gonen, Han Liu, Shugaku Takeda, Martin H. Voss, Satish K. Tickoo, Victor E. Reuter, Paul Russo, Emily H. Cheng, Chris Sander, Robert J. Motzer, James J. Hsieh
PDF File - 357K, (A) Time to recurrence with SETD2 mutations in TCGA cohort (p= 0.002). (B) Time to recurrence curves for all other mutations in the TCGA cohort, all other mutations non-significant for TTR.